{"id":6195,"date":"2017-09-06T16:39:31","date_gmt":"2017-09-06T21:39:31","guid":{"rendered":"https:\/\/www.institutionalinvestorsecuritiesblog.com\/?p=1759"},"modified":"2022-03-22T12:44:07","modified_gmt":"2022-03-22T17:44:07","slug":"mutual-fund-lord-abbetts-institutional-investor-fraud-lawsuit-valeant-pharmaceuticals-seek-three-times-losses-alleged","status":"publish","type":"post","link":"https:\/\/www.investorlawyers.com\/blog\/mutual-fund-lord-abbetts-institutional-investor-fraud-lawsuit-valeant-pharmaceuticals-seek-three-times-losses-alleged\/","title":{"rendered":"Mutual Fund Lord Abbett\u2019s Institutional Investor Fraud Lawsuit Against Valeant Pharmaceuticals Could Seek Over Three Times The Losses Alleged"},"content":{"rendered":"

\t\t\t\tLord Abbett is suing Valeant Pharmaceuticals contending that the defendant violated New Jersey\u2019s RICO law. The institutional investor is claiming $80B in losses. By invoking the state\u2019s RICO law, Lord Abbett could seek a penalty three times greater than the actual losses it allegedly suffered when the pharmaceutical company\u2019s share price went down.<\/p>\n

According to the mutual fund company, it purchased Valeant\u2019s debt securities at a price that was artificially inflated after the pharmaceutical company provided it with information that wasn\u2019t correct. Now, Lord Abbett is alleging violations of RICO law in NJ, which is where Valeant is headquartered. <\/p>\n

The institutional investor is not the only party to file a RICO case against Valeant. The other complaints are primarily over allegations that the pharmaceutical company committed fraud by engaging in business practices that were deceptive, including charging too much for drugs. These plaintiffs are claiming hundreds of millions of dollars of losses. <\/p>\n

Continue Reading \u203a<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Lord Abbett is suing Valeant Pharmaceuticals contending that the defendant violated New Jersey\u2019s RICO law. The institutional investor is claiming $80B in losses. By invoking the state\u2019s RICO law, Lord Abbett could seek a penalty three times greater than the actual losses it allegedly suffered when the pharmaceutical company\u2019s share price went down. According to […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":""},"categories":[1],"tags":[2886,2887],"class_list":["post-6195","post","type-post","status-publish","format-standard","hentry","category-uncategorized","tag-lord-abbett","tag-valeant-pharmaceuticals"],"yoast_head":"\nMutual Fund Lord Abbett\u2019s Institutional Investor Fraud Lawsuit Against Valeant Pharmaceuticals Could Seek Over Three Times The Losses Alleged — Investor Lawyers Blog — September 6, 2017<\/title>\n<meta name=\"description\" content=\"Lord Abbett is suing Valeant Pharmaceuticals contending that the defendant violated New Jersey\u2019s RICO law. The institutional investor is claiming $80B in — September 6, 2017\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.investorlawyers.com\/blog\/mutual-fund-lord-abbetts-institutional-investor-fraud-lawsuit-valeant-pharmaceuticals-seek-three-times-losses-alleged\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Mutual Fund Lord Abbett\u2019s Institutional Investor Fraud Lawsuit Against Valeant Pharmaceuticals Could Seek Over Three Times The Losses Alleged — Investor Lawyers Blog — September 6, 2017\" \/>\n<meta name=\"twitter:description\" content=\"Lord Abbett is suing Valeant Pharmaceuticals contending that the defendant violated New Jersey\u2019s RICO law. The institutional investor is claiming $80B in — September 6, 2017\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Shepherd Smith Edwards & Kantas, LLP\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mutual Fund Lord Abbett\u2019s Institutional Investor Fraud Lawsuit Against Valeant Pharmaceuticals Could Seek Over Three Times The Losses Alleged — Investor Lawyers Blog — September 6, 2017","description":"Lord Abbett is suing Valeant Pharmaceuticals contending that the defendant violated New Jersey\u2019s RICO law. The institutional investor is claiming $80B in — September 6, 2017","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.investorlawyers.com\/blog\/mutual-fund-lord-abbetts-institutional-investor-fraud-lawsuit-valeant-pharmaceuticals-seek-three-times-losses-alleged\/","twitter_card":"summary_large_image","twitter_title":"Mutual Fund Lord Abbett\u2019s Institutional Investor Fraud Lawsuit Against Valeant Pharmaceuticals Could Seek Over Three Times The Losses Alleged — Investor Lawyers Blog — September 6, 2017","twitter_description":"Lord Abbett is suing Valeant Pharmaceuticals contending that the defendant violated New Jersey\u2019s RICO law. The institutional investor is claiming $80B in — September 6, 2017","twitter_misc":{"Written by":"Shepherd Smith Edwards & Kantas, LLP","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.investorlawyers.com\/blog\/mutual-fund-lord-abbetts-institutional-investor-fraud-lawsuit-valeant-pharmaceuticals-seek-three-times-losses-alleged\/#article","isPartOf":{"@id":"https:\/\/www.investorlawyers.com\/blog\/mutual-fund-lord-abbetts-institutional-investor-fraud-lawsuit-valeant-pharmaceuticals-seek-three-times-losses-alleged\/"},"author":{"name":"Shepherd Smith Edwards & Kantas, LLP","@id":"https:\/\/www.investorlawyers.com\/blog\/#\/schema\/person\/e0240e0754684b69f7d6a7de1b9f1431"},"headline":"Mutual Fund Lord Abbett\u2019s Institutional Investor Fraud Lawsuit Against Valeant Pharmaceuticals Could Seek Over Three Times The Losses Alleged","datePublished":"2017-09-06T21:39:31+00:00","dateModified":"2022-03-22T17:44:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.investorlawyers.com\/blog\/mutual-fund-lord-abbetts-institutional-investor-fraud-lawsuit-valeant-pharmaceuticals-seek-three-times-losses-alleged\/"},"wordCount":361,"keywords":["Lord Abbett","Valeant Pharmaceuticals"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.investorlawyers.com\/blog\/mutual-fund-lord-abbetts-institutional-investor-fraud-lawsuit-valeant-pharmaceuticals-seek-three-times-losses-alleged\/","url":"https:\/\/www.investorlawyers.com\/blog\/mutual-fund-lord-abbetts-institutional-investor-fraud-lawsuit-valeant-pharmaceuticals-seek-three-times-losses-alleged\/","name":"Mutual Fund Lord Abbett\u2019s Institutional Investor Fraud Lawsuit Against Valeant Pharmaceuticals Could Seek Over Three Times The Losses Alleged — Investor Lawyers Blog — September 6, 2017","isPartOf":{"@id":"https:\/\/www.investorlawyers.com\/blog\/#website"},"datePublished":"2017-09-06T21:39:31+00:00","dateModified":"2022-03-22T17:44:07+00:00","author":{"@id":"https:\/\/www.investorlawyers.com\/blog\/#\/schema\/person\/e0240e0754684b69f7d6a7de1b9f1431"},"description":"Lord Abbett is suing Valeant Pharmaceuticals contending that the defendant violated New Jersey\u2019s RICO law. The institutional investor is claiming $80B in — September 6, 2017","breadcrumb":{"@id":"https:\/\/www.investorlawyers.com\/blog\/mutual-fund-lord-abbetts-institutional-investor-fraud-lawsuit-valeant-pharmaceuticals-seek-three-times-losses-alleged\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.investorlawyers.com\/blog\/mutual-fund-lord-abbetts-institutional-investor-fraud-lawsuit-valeant-pharmaceuticals-seek-three-times-losses-alleged\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.investorlawyers.com\/blog\/mutual-fund-lord-abbetts-institutional-investor-fraud-lawsuit-valeant-pharmaceuticals-seek-three-times-losses-alleged\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.investorlawyers.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Mutual Fund Lord Abbett\u2019s Institutional Investor Fraud Lawsuit Against Valeant Pharmaceuticals Could Seek Over Three Times The Losses Alleged"}]},{"@type":"WebSite","@id":"https:\/\/www.investorlawyers.com\/blog\/#website","url":"https:\/\/www.investorlawyers.com\/blog\/","name":"Investor Lawyers Blog","description":"Published By Investment Fraud Attorneys \u2014 Shepherd Smith Edwards & Kantas, LLP","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.investorlawyers.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.investorlawyers.com\/blog\/#\/schema\/person\/e0240e0754684b69f7d6a7de1b9f1431","name":"Shepherd Smith Edwards & Kantas, LLP","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/c7f8f04990816cd4044977eb59908da8c8d1ae487cc919cebd7027b74a0740a3?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c7f8f04990816cd4044977eb59908da8c8d1ae487cc919cebd7027b74a0740a3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c7f8f04990816cd4044977eb59908da8c8d1ae487cc919cebd7027b74a0740a3?s=96&d=mm&r=g","caption":"Shepherd Smith Edwards & Kantas, LLP"},"sameAs":["https:\/\/www.investorlawyers.com\/"]}]}},"jetpack_featured_media_url":"","jetpack_shortlink":"https:\/\/wp.me\/pedX9K-1BV","_links":{"self":[{"href":"https:\/\/www.investorlawyers.com\/blog\/wp-json\/wp\/v2\/posts\/6195","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.investorlawyers.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.investorlawyers.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.investorlawyers.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.investorlawyers.com\/blog\/wp-json\/wp\/v2\/comments?post=6195"}],"version-history":[{"count":1,"href":"https:\/\/www.investorlawyers.com\/blog\/wp-json\/wp\/v2\/posts\/6195\/revisions"}],"predecessor-version":[{"id":24808,"href":"https:\/\/www.investorlawyers.com\/blog\/wp-json\/wp\/v2\/posts\/6195\/revisions\/24808"}],"wp:attachment":[{"href":"https:\/\/www.investorlawyers.com\/blog\/wp-json\/wp\/v2\/media?parent=6195"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.investorlawyers.com\/blog\/wp-json\/wp\/v2\/categories?post=6195"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.investorlawyers.com\/blog\/wp-json\/wp\/v2\/tags?post=6195"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}